FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and concerns complex based on micro-bubbles for therapeutic agent delivery to target tissue containing micro-bubble with outer shell containing mixture of native and denatured albumin and hollow core, encapsulating gas perfluorocarbon; therapeutic agent; bifunctional linker. Group of inventions also concerns method of delivering above complex based on micro-bubbles to target tissue.
EFFECT: group of inventions provides increased binding of therapeutic agents with micro-bubbles to minimize non-targeted delivery of said agent.
17 cl, 4 ex, 10 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
SONODYNAMIC THERAPY | 2016 |
|
RU2791572C1 |
HIGH-EFFICIENCY SCREENING COMPOUNDS MODULATING EXPRESSION OF CELL MACROMOLECULES | 2012 |
|
RU2612017C2 |
NEW OLIGONUCLEOTIDES CONJUGATES AND USE THEREOF | 2012 |
|
RU2599449C1 |
METHOD OF PRODUCING PROTEIN NANOPARTICLES FROM IMMUNOGLOBULIN MOLECULES | 2021 |
|
RU2820320C2 |
COVALENTLY LINKED CONJUGATES CHELICAR-ANTIBODY AGAINST CHELICAR AND USE THEREOF | 2014 |
|
RU2694981C2 |
COMPOUNDS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | 2015 |
|
RU2703416C2 |
COMPOSITION OF DELIVERY SYSTEM BASED ON CONJUGATE FOR RNA-INTERFERENCE POLYNUCLEOTIDE DELIVERY TO LIVER CELL AND PROCESS FOR ITS PREPARATION | 2011 |
|
RU2623160C9 |
METHOD FOR SELECTION AND PRODUCTION OF SELECTIVE AND MULTISPECIFIC THERAPEUTIC MOLECULES WITH SPECIFIED PROPERTIES, INCLUDING, AT LEAST TWO, DIFFERENT TARGET GROUPS, AND THEIR APPLICATIONS | 2013 |
|
RU2644263C2 |
BISPECIFIC ANTI-HAPTEN/ANTI-BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES, COMPLEXES THEREOF AND THEIR USE AS BLOOD BRAIN BARRIER SHUTTLES | 2014 |
|
RU2693438C2 |
COVALENT BONDED POLYPEPTIDE TOXIN AND ANTIBODY CONJUGATES | 2014 |
|
RU2682754C2 |
Authors
Dates
2017-03-15—Published
2012-09-18—Filed